Clinical Trial Update: Safety & Efficacy of Peginesatide for Maintenance Treatment of Anemia in Participants With Chronic Kidney Disease on Hemodialysis [Phase 3]

View source ↗

Summary

Phase 3 study update evaluates the safety and efficacy of peginesatide for maintenance treatment of anemia in adults with chronic kidney disease on hemodialysis…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anemia
• Chronic Kidney Disease

Drugs mentioned

• Peginesatide (peginesatide)

Snippet

Sponsor: Affymax | Conditions: Chronic Renal Failure, Chronic Kidney Disease | Phase 3 | Status: COMPLETED | Results posted: 2012-07-30